Homeopathy
DOI: 10.1055/s-0039-1697927
Original Research Article
The Faculty of Homeopathy

Efficacy of Homeopathy in Addition to a Multidisciplinary Intervention for Overweight or Obesity in Mexican Adolescents: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Emma Macías-Cortés
1  Servicio de Consulta Externa de Homeopatía, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
,
Saraí Arellano-Álvarez
2  Servicio de Medicina del Deporte, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
,
Sandra Vega-Monroy
3  Servicio de Nutrición, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
,
Violeta Vera-Pérez
4  Servicio de Terapia Familiar, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
,
Lidia Llanes-González
5  Unidad de Salud Mental Comunitaria, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
,
Pilar Sánchez-Navarrete
6  Jefatura de Consulta Externa, Hospital Nacional Homeopático, Secretaría de Salud, Alcaldía Cuauhtémoc, Mexico City, Mexico
,
Dolores Enciso-González
2  Servicio de Medicina del Deporte, Hospital Juárez de México, Secretaría de Salud, Alcaldía Gustavo A. Madero, Mexico City, Mexico
› Author Affiliations
Funding No external funding was provided.
Further Information

Publication History

27 May 2019

14 August 2019

Publication Date:
20 January 2020 (online)

Abstract

Background Current recommendations for treating obesity in adolescence include a comprehensive approach (nutritional, behavioral, and exercise). Calcarea carbonica ostrearum (CCO) is a homeopathic medicine usually prescribed in obese individuals, but its effects on weight and body fat are not completely known.

Objective The aim of this study will be to evaluate the efficacy of homeopathic CCO, in addition to a multidisciplinary intervention (diet, motivational support, and exercise program), on body fat and weight in obese adolescents.

Methods/Design A randomized, placebo-controlled, double-blind, parallel-group, superiority trial with 3-month study duration will be undertaken. The study will be conducted in a public research hospital in Mexico City, Hospital Juárez de México, in the outpatient services of homeopathy and sports medicine. Eighty non-diabetic adolescents, 12 to 19 years old, who are overweight or obese, will be included. The primary outcome: change in body fat percentage at week 12. The secondary outcomes: change in mean total weight, total body mass index, fat mass index, waist–hip ratio, lean muscle mass, fasting glucose, insulin, insulin resistance, lipid profile, score of Center for Epidemiologic Studies Depression Scale Revised (CESD-R) and score of Screen for Child Anxiety-Related Emotional Disorders (SCARED) at week 12. Efficacy data will be analyzed in the intention-to-treat sample. To determine the difference in the outcomes between groups at baseline and week 12, data will be analyzed using Student's t-test.

Discussion This is the first randomized controlled trial aimed to determine the fat-reducing efficacy in obese adolescents of a homeopathic medicine, CCO, given in addition to a multidisciplinary intervention, compared with placebo plus the same intervention. It is an attempt to support scientific evidence in homeopathy for one of the most common chronic diseases, which causes high mortality due to its complications.

ClinicalTrials.gov Identifier: NCT03945396https://clinicaltrials.gov/ct2/show/NCT03945396?term=homeopathy+for+obesity+in+Mexican+adolescents&rank=1

Highlights

1. Calcarea carbonica ostrearum (CCO) is a homeopathic medicine usually prescribed in obese individuals, but its effects on weight and body fat are not completely known.


2. The aim of this randomized controlled trial is to evaluate the efficacy of CCO, given in addition to a multidisciplinary intervention (diet, exercise program, and motivational support), in reducing percentage of body fat.


3. Eighty non-diabetic adolescents, 12 to 19 years old, who are overweight or obese, will be included.


4. Primary outcome is the change in mean body fat percentage at week 12.


5. Study participants will receive a comprehensive approach, including clinical evaluation, with assessment of severity of depression and anxiety, as well as anthropometric, and laboratory-derived measurements.


Dr. Pilar Sánchez-Navarrete, who conceived the original design for this study, died on November 17, 2011.